Of the study cohort, 55 patients had local NGS performed at the time of the initial diagnosis of advanced NSCLC with results reported, and 18 had NGS performed at the time of resistance to ALK TKI(s). This evidence concerns the gene ALK and non-small cell lung carcinoma.